A RETROSPECTIVE ANALYSIS OF THE EFFICACY AND SAFETY OF REGORAFENIB IN PATIENTS WITH CHEMO-REFRACTORY COLORECTAL CANCER

被引：0
|
作者：
Oishi, Takayuki [1 ]
Takahashi, Masanobu [2 ]
Shiono, Masatoshi [2 ]
Takahashi, Shin [1 ]
Akiyama, Shoko [2 ]
Shirota, Hidekazu [2 ]
Shimodaira, Hideki [2 ]
Kato, Shunsuke [1 ]
Ishioka, Chikashi [1 ]
机构：
[1] Tohoku Univ, IDAC, Dept Clin Oncol, Sendai, Miyagi 980, Japan
[2] Tohoku Univ Hosp, Dept Clin Oncol, Sendai, Miyagi, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu436.27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-12-2
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A meta-analysis of safety and efficacy of regorafenib for refractory metastatic colorectal cancer
    Xue, Wu-Song
    Men, Si-Ye
    Liu, Wei
    Liu, Reng-Hai
    MEDICINE, 2018, 97 (40)
  • [2] Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study
    Bayoglu, Ibrahim V.
    Yildiz, Ibrahim
    Varol, Umut
    Cokmert, Suna
    Alacacioglu, Ahmet
    Kucukzeybek, Yuksel
    Akyol, Murat
    Demir, Lutfiye
    Dirican, Ahmet
    Tarhan, Oktay
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2015, 19 (05): : 385 - 390
  • [3] Proteogenomic analysis of chemo-refractory serous ovarian cancer
    Chowdhury, Shrabanti
    Kennedy, Jacob J.
    Ivey, Richard G.
    Murillo, Oscar D.
    Hosseini, Noshad
    Song, Xiaoyu
    Petralia, Francesca
    Calinawan, Anna
    Savage, Sara R.
    Berry, Anna B.
    Reva, Boris
    Ozbek, Umut
    Krek, Azra
    Ma, Weiping
    Leprevost, Felipe da Veiga
    Ji, Jiayi
    Yoo, Seungyeul
    Lin, Chenwei
    Voytovich, Uliana J.
    Huang, Yajue
    Lee, Sun-Hee
    Bergan, Lindsay
    Lorentzen, Travis D.
    Mesri, Mehdi
    Rodriguez, Henry
    Hoofnagle, Andrew N.
    Herbert, Zachary T.
    Nesvizhskii, Alexey I.
    Zhang, Bing
    Whiteaker, Jeffrey R.
    Fenyo, David
    McKerrow, Wilson
    Wang, Joshua
    Schuer, Stephan C.
    Stathias, Vasileios
    Chen, X. Steven
    Barcellos-Hoff, Mary Helen
    Starr, Timothy K.
    Winterhoff, Boris J.
    Nelson, Andrew C.
    Mok, Samuel C.
    Kaufmann, Scott H.
    Drescher, Charles
    Cieslik, Marcin
    Wang, Pei
    Birrer, Michael J.
    Paulovich, Amanda G.
    CELL, 2023, 186 (16) : 3476 - +
  • [4] The efficacy and safety of sintilimab plus regorafenib in refractory metastatic colorectal cancer.
    Li, Rongrong
    Liu, Zhenyang
    Yin, Xianli
    Zeng, Deyu
    Jiang, Shaofeng
    Liu, Wu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15546 - E15546
  • [5] Sidedness and survival of chemo-refractory metastatic colorectal cancer treated with lonsurf or regorafenib: A nationwide population-based study in Taiwan
    Hsieh, M-C.
    Chen, H-P.
    Rau, K-M.
    Lin, S-E.
    Liu, K-W.
    Chiu, C-C.
    Chen, C-I.
    Song, L-C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1515 - S1515
  • [6] Efficacy and Safety of Regorafenib or TAS-102 in Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies
    Sueda, Toshinori
    Sakai, Daisuke
    Kudo, Toshihiro
    Sugiura, Takashi
    Takahashi, Hidekazu
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Hata, Taishi
    Hayashi, Taro
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Mori, Masaki
    Satoh, Taroh
    ANTICANCER RESEARCH, 2016, 36 (08) : 4299 - 4306
  • [7] Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: a retrospective cohort study
    Yan, Hao
    Liu, Jindong
    Zhang, Yifan
    Chen, Shuo
    Xu, Jing
    Gao, Dandan
    Li, Haipeng
    Fang, Xinyue
    Wang, Yu
    Wang, Huaqing
    Wang, Hui
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (03) : 987 - 1001
  • [8] Retrospective analysis of the efficacy and safety of regorafenib in patients with advanced GIST
    Nakatsumi, H.
    Komatsu, Y.
    Saito, R.
    Ito, K.
    Nakano, S.
    Kawamoto, Y.
    Yuki, S.
    Sakamoto, N.
    ANNALS OF ONCOLOGY, 2019, 30 : 15 - 15
  • [9] Eligibility of real-world patients with chemo-refractory, K-RAS wild-type, metastatic colorectal cancer for palliative intent regorafenib monotherapy
    Angeles, Arkhjamil
    Hung, Wayne
    Cheung, Winson Y.
    MEDICAL ONCOLOGY, 2018, 35 (08)
  • [10] Efficacy and safety of regorafenib compared to TAS-102 for refractory metastatic colorectal cancer
    Abrahao, Ana Beatriz Kinupe
    Ko, Yoo-Joung
    Chan, Kelvin K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345